The Scientist

» biotechnology and microbiology

Most Recent

image: CAR-T Therapies Get $1 Billion Boost

CAR-T Therapies Get $1 Billion Boost

By | July 1, 2015

The biotech firm Celgene inks a huge collaboration deal with Juno Therapeutics to develop and commercialize new cancer immunotherapies.


image: Gutless Worm

Gutless Worm

By | July 1, 2015

Meet the digestive tract–lacking oligochaete that has fueled Max Planck researcher Nicole Dubilier’s interest in symbiosis and marine science.


image: Sold on Symbiosis

Sold on Symbiosis

By | July 1, 2015

A love of the ocean lured Nicole Dubilier into science; gutless sea worms and their nurturing bacterial symbionts keep her at the leading edge of marine microbiology.


image: Sponging Up Phosphorus

Sponging Up Phosphorus

By | July 1, 2015

Symbiotic bacteria in Caribbean reef sponges store polyphosphate granules, possibly explaining why phosphorous is so scarce in coral reef ecosystems.

1 Comment

image: The Sum of Our Parts

The Sum of Our Parts

By and | July 1, 2015

Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.


image: Celladon Shutters Its R&D

Celladon Shutters Its R&D

By | June 26, 2015

Biotech firm likely to pull the plug after its gene therapy product fails.


image: Week in Review: June 22–26

Week in Review: June 22–26

By | June 26, 2015

Neanderthal-human hybrid discovered; the neurobiology of fear behavior; and an insulin patch that responds to high glucose levels in mice


image: Organ-on-a-Chip Gets Big Pharma Boost

Organ-on-a-Chip Gets Big Pharma Boost

By | June 18, 2015

Johnson & Johnson agrees to use Emulate’s blood-clot device in three of its preclinical drug programs.


image: Optogenetics Meets CRISPR

Optogenetics Meets CRISPR

By | June 15, 2015

Researchers in Japan have developed a photoactivatable Cas9 nuclease to control CRISPR-based gene editing with the flip of a switch.


image: Synthetic Biology Entrepreneur Dies

Synthetic Biology Entrepreneur Dies

By | June 11, 2015

Austen Heinz, who founded Cambrian Genomics to custom print DNA and had grand ideas about designing organisms, has passed away at age 31.


Popular Now

  1. Rethinking the Rise of Mammals
    Daily News Rethinking the Rise of Mammals

    Mammals diversified 30 million years later than previously estimated, according to a new analysis of an ancient fossil.

  2. Wiping Out Gut Bugs Stops Obesity
  3. Birth of the Skin Microbiome
    Daily News Birth of the Skin Microbiome

    The immune system tolerates the colonization of commensal bacteria on the skin with the aid of regulatory T cells during the first few weeks of life, a mouse study shows.

  4. Battling the Bulge
    Bio Business Battling the Bulge

    Weight-loss drugs that target newly characterized obesity-related receptors and pathways could finally offer truly effective fat control.

Life Technologies